Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-11-08
1997-07-22
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31385
Patent
active
056504292
ABSTRACT:
The invention relates to the use of DL-(+/-)-.alpha. lipoic acid, D-(+)-.alpha.-lipoic acid, L-(-)-.alpha.-lipoic acid in reduced or oxidized form or of the metabolites and salts, esters, amides thereof for the preparation of medicines for the treatment of disorders caused by changes or disturbances in the rheological properties of the blood such as blood viscosity, erythrocyte flexibility and the aggregation of erythrocytes, in particular for the treatment of microangiopathy with disturbed microcirculation. It can also be used in the treatment of diabetics and of dialysis patients for protection of the erythrocytes, in central and peripheral circulatory disturbances and in tinnitus and hearing loss.
REFERENCES:
patent: 5318987 (1994-06-01), Weithmann et al.
The Merck Index, 11th edition, p. 1469, cit#9255 1989.
WPI Abstract of Canadian Patent 2133861 (Koel Tringer) Apr. 1995.
Conrad Frank
Geise Wolfgang
Henrich Hermann-August
Ulrich Heinz
Asta Medica Aktiengesellschaft
Henley III Raymond
LandOfFree
Use of DL-(+/-)-.alpha.-lipoic acid, D-(+)-.alpha.-lipoic acid, does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of DL-(+/-)-.alpha.-lipoic acid, D-(+)-.alpha.-lipoic acid, , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of DL-(+/-)-.alpha.-lipoic acid, D-(+)-.alpha.-lipoic acid, will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1560274